FDA Clears Sarasota-Based NeuroDR Stroke Software
Deep Reasoning AI received 510(k) clearance for software that visualizes head and neck arteries on CTA scans.
Updated on Oct. 28, 2026 in Stroke
Live Poll
Do you trust AI-assisted software to accurately assist in medical diagnostic imaging?
The FDA has granted 510(k) clearance to the NeuroDR software developed by Sarasota-based company Deep Reasoning AI. The technology automatically processes medical images to assist clinicians in evaluating lesions and planning patient treatments.
Why it matters
This clearance provides medical professionals with a new tool to visualize complex arterial structures. By automating the removal of bone, soft tissue, and veins from scans, the system supports more efficient documentation and clinical planning.
The NeuroDR system received 510(k) regulatory clearance to process head and neck artery visualizations. Performance validation for the software was established through studies conducted by 3DR Labs.
The players
Deep Reasoning AI
This Sarasota, Florida-based firm specializes in developing artificial intelligence solutions for medical imaging and clinical diagnostic workflows.
3DR Labs
This organization specializes in advanced post-processing of medical imaging and conducted the performance studies required for this regulatory approval.
Innolitics
This consulting firm provides regulatory and engineering expertise, specifically managing the submission and review process for medical device clearances.
The details
The software automatically isolates arteries by stripping away bone, soft tissue, and veins from CTA scans. It transmits 3D images and volume renderings directly to a facility's Picture Archiving and Communication System (PACS) as DICOM files.
Timeline
The FDA officially granted 510(k) clearance to the NeuroDR software on October 28, 2026.
Health Landscape
This clearance follows the regulatory pattern established by the FDA's 510(k) premarket notification pathway to ensure new diagnostic tools meet safety and efficacy standards. It reflects a broader trend of integrating automated AI image processing into neurological care.
By streamlining the visualization of arterial lesions, this technology may help clinicians plan complex surgeries or treatments with greater speed. Local patients benefit from more efficient imaging workflows that reduce the time needed for diagnostic review.
The takeaway
The implementation of specialized software like NeuroDR can significantly reduce the time radiologists spend manually processing diagnostic scans. Clinicians can now focus on lesion evaluation rather than the technical overhead of 3D image reconstruction.
Further reading
For more information on the diagnostic tools used in modern vascular care, visit the Stroke section.
Source note: This article includes information reported by AuntMinnie.
Live Poll
Do you trust AI-assisted software to accurately assist in medical diagnostic imaging?
